Literature DB >> 10622540

Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan.

K Koike, K Shimotouno, S Okada, H Okamoto, N Hayashi, K Ueda, S Kaneko, K Koike, O Yokosuka, T Chiba, H Marusawa, O Hino, T Utida, M Omata, T Juji, N Nojiri, K Takada, T Miyamura, T Osuga, Y Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10622540      PMCID： PMC5926023          DOI： 10.1111/j.1349-7006.1999.tb00707.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


× No keyword cloud information.
  10 in total

1.  High prevalence of co-occurrence of anti-HCV and anti-HBc antibodies in chronic hepatitis patients from southern Italy.

Authors:  G B Gaeta; M Rapicetta; C Sardaro; P Chionne; A Costantino; G Giusti
Journal:  Ital J Gastroenterol       Date:  1990-12

2.  Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients.

Authors:  K Koike; M Kobayashi; M Gondo; I Hayashi; T Osuga; S Takada
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

3.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

Authors:  D E Koziol; P V Holland; D W Alling; J C Melpolder; R E Solomon; R H Purcell; L M Hudson; F J Shoup; H Krakauer; H J Alter
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

5.  Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues.

Authors:  S Takada; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants.

Authors:  S Uemoto; K Sugiyama; H Marusawa; Y Inomata; K Asonuma; H Egawa; T Kiuchi; Y Miyake; K Tanaka; T Chiba
Journal:  Transplantation       Date:  1998-02-27       Impact factor: 4.939

7.  Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.

Authors:  T Urashima; K Saigo; S Kobayashi; H Imaseki; H Matsubara; Y Koide; T Asano; Y Kondo; K Koike; K Isono
Journal:  J Hepatol       Date:  1997-04       Impact factor: 25.083

8.  Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.

Authors:  C Bréchot; F Jaffredo; D Lagorce; G Gerken; K Meyer zum Büschenfelde; A Papakonstontinou; S Hadziyannis; R Romeo; M Colombo; J Rodes; J Bruix; R Williams; N Naoumov
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

9.  Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen.

Authors:  A L Mason; L Xu; L Guo; M Kuhns; R P Perrillo
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

10.  Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Authors:  S Okada; T Sato; T Okusaka; H Ishii; M Ikeda; H Nakasuka; H Kosakamoto; M Yoshimori; K Wakabayashi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  10 in total
  5 in total

1.  Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.

Authors:  Anna S Lok; James E Everhart; Adrian M Di Bisceglie; Hae-Young Kim; Munira Hussain; Timothy R Morgan
Journal:  Hepatology       Date:  2011-08       Impact factor: 17.425

2.  Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Akira Hiraide; Hiromitsu Saisho
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

Review 3.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 4.  Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.

Authors:  Kashif Asghar; Asim Farooq; Bilal Zulfiqar; Muhammad Usman Rashid
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

Review 5.  Occult Hepatitis B Virus Infection: An Update.

Authors:  Carlo Saitta; Teresa Pollicino; Giovanni Raimondo
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.